Population-Based Incidence of Cervical Intraepithelial Neoplasia Across 14 Years of HPV Vaccination

Rachael Adcock; Huining Kang; Philip E Castle; Walter Kinney; Rebecca T Emeny; Charles Wiggins; Cosette M Wheeler

doi:10.1001/jamaoncol.2024.2673

Population-Based Incidence of Cervical Intraepithelial Neoplasia Across 14 Years of HPV Vaccination

JAMA Oncol. 2024 Sep 1;10(9):1287-1290. doi: 10.1001/jamaoncol.2024.2673.

Authors

Rachael Adcock¹, Huining Kang¹, Philip E Castle^{2

3}, Walter Kinney⁴, Rebecca T Emeny¹, Charles Wiggins⁵, Cosette M Wheeler¹

Affiliations

¹ University of New Mexico Center for HPV Prevention, New Mexico HPV Pap Registry, Albuquerque.
² Division of Cancer Prevention and Cancer Epidemiology, National Cancer Institute, Rockville, Maryland.
³ Division of Genetics, National Cancer Institute, Rockville, Maryland.
⁴ Sacramento, California.
⁵ University of New Mexico Comprehensive Cancer Center, New Mexico Tumor Registry, Albuquerque.

PMID: 39052303
PMCID: PMC11273280 (available on 2025-07-25)
DOI: 10.1001/jamaoncol.2024.2673

No abstract available

Plain language summary

This cohort study examines the incidence of cervical intraepithelial neoplasia during a period of increasing human papillomavirus (HPV) vaccination coverage from 2007 to 2020.

MeSH terms

Adolescent
Adult
Female
Humans
Incidence
Middle Aged
Papillomavirus Infections* / complications
Papillomavirus Infections* / epidemiology
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines* / administration & dosage
Papillomavirus Vaccines* / therapeutic use
Time Factors
United States / epidemiology
Uterine Cervical Dysplasia* / epidemiology
Uterine Cervical Dysplasia* / prevention & control
Uterine Cervical Dysplasia* / virology
Uterine Cervical Neoplasms* / epidemiology
Uterine Cervical Neoplasms* / prevention & control
Uterine Cervical Neoplasms* / virology
Vaccination* / statistics & numerical data
Young Adult

Substances

Papillomavirus Vaccines